نتایج جستجو برای: lysosomal storage

تعداد نتایج: 196223  

2013
Carmine Settembre Andrea Ballabio

Lysosomal storage disorders (LSDs) are inherited diseases characterized by progressive intracellular accumulation of undigested macromolecules within the cell due to specific lysosomal defects. Lysosomal storage results in a global impairment ofmany lysosome‐dependent pathways (e.g. autophagy and endocytosis), leading to cellular dysfunction and death (Ballabio &Gieselmann, 2009). LSD patients ...

Journal: :FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2009
Lena Wartosch Jens C Fuhrmann Michaela Schweizer Tobias Stauber Thomas J Jentsch

Mutations in either ClC-7, a late endosomal/lysosomal member of the CLC family of chloride channels and transporters, or in its beta-subunit Ostm1 cause osteopetrosis and lysosomal storage disease in mice and humans. The severe phenotype of mice globally deleted for ClC-7 or Ostm1 and the absence of storage material in cultured cells hampered investigations of the mechanism leading to lysosomal...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2003
Carole Vogler Nancy Galvin Beth Levy Jeffery Grubb Jinxing Jiang Xiao Yan Zhou William S Sly

beta-Glucuronidase (GUSB) is a lysosomal enzyme important in the normal step-wise degradation of glycosaminoglycans. Deficiency of GUSB causes the lysosomal storage disease mucopolysaccharidosis VII (MPS VII, Sly disease). Affected patients have widespread progressive accumulation of beta-glucuronide-containing glycosaminoglycans in lysosomes. Enzyme replacement, bone marrow transplantation, an...

Journal: :Blood 2014
Anneliese O Speak Danielle Te Vruchte Lianne C Davis Anthony J Morgan David A Smith Nicole M Yanjanin Louise Simmons Ralf Hartung Heiko Runz Eugen Mengel Michael Beck Jackie Imrie Elizabeth Jacklin James E Wraith Christian Hendriksz Robin Lachmann Celine Cognet Rohini Sidhu Hideji Fujiwara Daniel S Ory Antony Galione Forbes D Porter Eric Vivier Frances M Platt

Niemann-Pick type C (NPC) is a neurodegenerative lysosomal storage disorder caused by defects in the lysosomal proteins NPC1 or NPC2. NPC cells are characterized by reduced lysosomal calcium levels and impaired sphingosine transport from lysosomes. Natural killer (NK) cells kill virally infected/transformed cells via degranulation of lysosome-related organelles. Their trafficking from lymphoid ...

Journal: :Biochemical Society transactions 2010
Alessandra d'Azzo Erik Bonten

The lysosomal system comprises a specialized network of organelles crucial for the sorting, digestion, recycling and secretion of cellular components. With their content of hydrolytic enzymes, lysosomes regulate the degradation of a multitude of substrates that reach these organelles via the biosynthetic or the endocytic route. Gene defects that affect one or more of these hydrolases lead to LS...

2017
Lin Liu Wang-Sik Lee Balraj Doray Stuart Kornfeld

Several lysosomal enzymes currently used for enzyme replacement therapy in patients with lysosomal storage diseases contain very low levels of mannose 6-phosphate, limiting their uptake via mannose 6-phosphate receptors on the surface of the deficient cells. These enzymes are produced at high levels by mammalian cells and depend on endogenous GlcNAc-1-phosphotransferase α/β precursor to phospho...

2012
Fiona L. Wilkinson Rebecca J. Holley Kia J. Langford-Smith Soumya Badrinath Aiyin Liao Alex Langford-Smith Jonathan D. Cooper Simon A. Jones J. Ed Wraith Rob F. Wynn Catherine L. R. Merry Brian W. Bigger

Mucopolysaccharide diseases (MPS) are caused by deficiency of glycosaminoglycan (GAG) degrading enzymes, leading to GAG accumulation. Neurodegenerative MPS diseases exhibit cognitive decline, behavioural problems and shortened lifespan. We have characterised neuropathological changes in mouse models of MPSI, IIIA and IIIB to provide a better understanding of these events.Wild-type (WT), MPSI, I...

2011
Umeharu Ohto Kimihito Usui Toshinari Ochi Kenjiro Yuki Yoshinori Satow Toshiyuki Shimizu

Background Deficiencies in β-D-galactosidase cause lysosomal storage diseases. Results This is the first to describe the crystal structure of human β-GAL. Human β-GAL is comprised of a TIM barrel domain and two -domains. Conclusion The mutations were classified as mutations directly affecting the ligand recognition, mutations inside the protein core, or mutations located in the protein surface...

Journal: :Bioorganic & medicinal chemistry letters 2010
Trisha A Duffey Tanvir Khaliq C Ronald Scott Frantisek Turecek Michael H Gelb

In continued efforts to develop enzymatic assays for lysosomal storage diseases appropriate for newborn screening laboratories we have synthesized novel and specific enzyme substrates for Maroteaux-Lamy (MPS VI) and Morquio A (MPS IVA) diseases. The sulfated monosaccharide derivatives were found to be converted to product by the respective enzyme in blood from healthy patients but not by blood ...

Journal: :Current gene therapy 2009
Dwight D Koeberl Priya S Kishnani

Significant advances in therapy for lysosomal storage disorders have occurred with an accelerating pace over the past decade. Although enzyme replacement therapy has improved the outcome of lysosomal storage disorders, antibody responses have occurred and sometimes prevented efficacy, especially in cross-reacting immune material negative patients with Pompe disease. Preclinical gene therapy exp...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید